Gilead Sciences, Inc.
GILD
$118.37
-$0.65-0.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.44% | 131.53% | 24.77% | -42.55% | 54.45% |
| Total Depreciation and Amortization | -0.43% | 0.87% | 0.73% | 0.88% | 1.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.25% | -87.35% | -97.31% | 292.71% | 100.36% |
| Change in Net Operating Assets | -30.27% | -125.05% | 188.95% | 141.45% | -567.07% |
| Cash from Operations | -37.58% | -20.82% | 37.16% | 145.53% | -43.33% |
| Capital Expenditure | 17.69% | 0.95% | 31.63% | -15.57% | 6.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 86.18% | 93.25% | 73.12% | -621.52% | 37.45% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,852.00% | -101.96% | 98.71% | 103.57% | 75.25% |
| Cash from Investing | -589.25% | 81.20% | 69.05% | -210.04% | 36.44% |
| Total Debt Issued | -- | -- | 346,300.00% | -- | -- |
| Total Debt Repaid | 99.51% | -- | -- | 95.02% | -- |
| Issuance of Common Stock | 440.00% | 72.60% | 565.38% | 18.07% | -80.77% |
| Repurchase of Common Stock | -427.00% | -82.50% | -133.33% | 0.00% | 33.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.26% | -2.02% | -3.18% | -3.15% | -2.97% |
| Other Financing Activities | -82.86% | -50.43% | -42.42% | -5.13% | -6.06% |
| Cash from Financing | 46.94% | -151.73% | 305.64% | 9.22% | -168.21% |
| Foreign Exchange rate Adjustments | 763.64% | 205.56% | -248.65% | 833.33% | -184.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.96% | -51.06% | 1,203.95% | 226,300.00% | -353.39% |